4 years ago

Inotec AMD Secures £3.7 Million for Wound Healing Innovation

  • Inotec AMD, a UK-based wound healing medtech firm, has raised £3.7 million in Series C funding led by Wealth Club

  • The investment will be used for commercial expansion in the US and other markets

  • Inotec AMD's patented NATROX oxygen therapy treatment has proven effective in healing previously untreatable wounds, including diabetic foot ulcers

  • The company has a strong track record of success, having supplied to the US Department of Veterans Affairs and treating over 1,000 patients

  • The investment was also backed by high-profile investors, including Amadeus Capital Partners and Jonathan Milner, of Abcam fame.

      • ProblemHealthcare

      "Healing untreatable wounds, even those that had been open for months or years, in any setting, at home or in-clinic"

      Solution

      "Applying oxygen therapy through patented NATROX system, which can heal or improve 88% of previously untreatable wounds"

      Covered on